ADHD in the News 2025-11-20

Kansas City is hosting nation’s largest ADHD conference as support comes under threat

Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD) chose Kansas City to host this year’s conference, covering topics from everyday life with ADHD to how the Trump administration is threatening school accommodations and research funding.



No, taking paracetamol while pregnant doesn’t cause autism or ADHD, major review finds

In a recent study published in the British Medical Journal (BMJ), researchers analyzed the quality, validity, and biases in existing evidence linking maternal paracetamol (acetaminophen) use during pregnancy with the risk of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in children.



Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.

Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been studied closely. ‘I was living in a body hijacked by the medication.’



US jury convicts founder of ADHD startup in Adderall fraud scheme

Nov 19 (Reuters) - The founder and a former top doctor at Done Global were convicted by a San Francisco jury of conspiring to distribute Adderall and other stimulants, in the first federal prosecution of alleged illegal drug distribution by a telehealth company. Ruthia He, who founded Done, and David Brody were each found guilty on Tuesday on two conspiracy counts and four counts of distributing controlled substances in their alleged $100 million fraud scheme. He was also convicted on an obstruction charge.



New Study Finds Novel Link Between Shared Brain-Gene Patterns and Autism Symptom Severity in Children With Autism and ADHD

New York, NY – A new study published in Molecular Psychiatry reveals that the biological underpinnings of autism and ADHD may transcend traditional diagnostic boundaries.



ADHD and Mild Cognitive Impairment/Early Dementia: A Clinical Reality

Key Takeaways: ADHD prevalence in older adults is estimated between 2.18% and 3.5%, with treatment rates significantly lower than diagnosis rates. Diagnosing ADHD in older adults is complex due to symptom overlap with other cognitive disorders and limited clinical training. Limited research on ADHD medications in older adults suggests stimulants may improve symptoms with manageable risks. Further research is needed to address the aging ADHD population and improve treatment strategies for maintaining quality of life.



Teens Should Steer Clear of Using AI Chatbots for Mental Health, Researchers Say

Teenagers should not use artificial intelligence chatbots for mental health advice or emotional support, warns a report released Nov. 20 by Stanford University’s Brain Science Lab, and Common Sense Media, a research and advocacy organization focused on youth and technology.



Youth with mental health conditions share strikingly similar brain changes, regardless of diagnosis

A major international study – the largest of its kind – has uncovered similar structural changes in the brains of young people diagnosed with anxiety disorders, depression, ADHD and conduct disorder, offering new insights into the biological roots of mental health conditions in children and young people.



Why There May Be a Link to ADHD and Substance Use Among Young Sexual Minority Men

Rutgers Health researchers reveal how attention difficulties and impulsivity may heighten vulnerability to early and frequent substance use among young sexual minority men



Omega-3 deficit linked to ADHD symptoms in Palestinian adolescents

Attention-deficit/hyperactivity disorder (ADHD) symptoms are influenced by socioeconomic factors in regions affected by conflict and resource limitations, a new study focusing on non-Western populations has found. The study also revealed that lower omega-3 fatty acid intake is significantly associated with higher ADHD symptom scores in Palestinian adolescents, reflecting findings from other research conducted in Western countries.



Discontinuation of ADHD medication more common in children with underweight

Children who are underweight are more likely to stop taking their ADHD medication within a year. These are the findings of a study conducted at the University of Gothenburg on methylphenidate, a common pharmacological treatment in ADHD. Behind the discontinuations are clear differences in dosage that can also be linked to gender and age.



New study explores how ADHD symptoms relate to menopause in midlife women

Women with attention-deficit/hyperactivity disorder (ADHD) often navigate a range of challenges that extend far beyond childhood. One area of increasing interest is how this condition interacts with the menopausal transition, a period marked by significant hormonal and cognitive shifts. A new study published in the Journal of Attention Disorders offers an in-depth look into this issue.



Study shows that ADHD awareness may lead to increase in false self-diagnosis, but intervention can help

Growing awareness of ADHD may be leading some young adults to mistakenly believe they have the disorder, according to new U of T Scarborough research. The study, published in Psychological Medicine, found that while mental health awareness programs are designed to help people recognize symptoms and seek support, they can trigger false self-diagnosis. But the researchers also found that a short educational session on the nocebo effect – a phenomenon in which negative expectations about having a disorder can make someone’s symptoms appear worse – can lower the likelihood of mistaken diagnosis.



Ann Arbor residents grapple with ADHD medication shortages and recalls

For Ann Arbor residents and University of Michigan students, filling a prescription for attention-deficit/hyperactivity disorder medication has long been an exercise in uncertainty. Even before the Oct. 28 recall of lisdexamfetamine dimesylate capsules, commonly known as Vyvanse, pharmacies in Ann Arbor and across the country have struggled for more than two years to keep key stimulant medications — including Adderall, Ritalin — consistently in stock.



A new spin on ADHD research

Julia Basso, Director of the Embodied Brain Laboratory, and Craig Arthur, Co-Director of Digging in the Crates, are collaborating on a research initiative to examine the potential of DJing as an intervention for Attention Deficit Hyperactivity Disorder (ADHD) in young adults.